Protagonist Therapeutics
PTGX
#3716
Rank
NZ$4.50 B
Marketcap
$76.50
Share price
3.07%
Change (1 day)
166.96%
Change (1 year)

Market capitalization of Protagonist Therapeutics (PTGX)

Market cap: NZ$4.50 Billion

As of September 2024 Protagonist Therapeutics has a market cap of NZ$4.50 Billion. This makes Protagonist Therapeutics the world's 3716th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Protagonist Therapeutics from 2016 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$4.50 B115.48%
2023NZ$2.09 B147.37%
2022NZ$0.84 B-64.53%
2021NZ$2.38 B97.66%
2020NZ$1.20 B323.92%
2019NZ$0.28 B22.33%
2018NZ$0.23 B-62.21%
2017NZ$0.61 B15.96%
2016NZ$0.53 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Protagonist Therapeutics was reported to be:

NZ$4.50 Billion
by Yahoo Finance info icon info icon
NZ$4.50 Billion
by CompaniesMarketCap info icon info icon
NZ$4.50 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$1.28 B-71.53%๐Ÿ‡บ๐Ÿ‡ธ USA